Catherine Mazzacco's most recent trade in Krystal Biotech Inc was a trade of 5,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 30, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Krystal Biotech Inc | Catherine Mazzacco | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2025 | 5,000 | 5,000 | - | - | Stock Option (Right to Buy) | |
| Sight Sciences Inc | Catherine Mazzacco | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 30,952 | 78,507 | - | 0 | Common Stock | |
| Krystal Biotech Inc | Catherine Mazzacco | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2024 | 5,000 | 5,000 | - | - | Stock Option (Right to Buy) | |
| Sight Sciences Inc | Catherine Mazzacco | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 17,366 | 47,555 | - | 0 | Common Stock | |
| Krystal Biotech Inc | Catherine Mazzacco | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 2,180 | 2,180 | - | - | Stock Option (Right to Buy) | |
| Sight Sciences Inc | Catherine Mazzacco | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 30,189 | 0 | - | 0 | Common Stock | |
| Krystal Biotech Inc | Catherine Mazzacco | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 13,600 | 13,600 | - | - | Stock Option (Right to Buy) |